New pill aims to revive Insulin-Making cells in type 1 diabetes

NCT ID NCT06152042

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 29 times

Summary

This study tested an experimental drug called BMF-219 in adults with type 1 diabetes. The goal was to see if it could help the body produce more of its own insulin, reducing the need for injected insulin. The trial was stopped early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Alliance for Multispecialty Research, LLC.

    Norman, Oklahoma, 73069, United States

  • Centricity Research

    Toronto, Ontario, Canada

  • Consano Clinical Research, LLC

    Shavano Park, Texas, 78231, United States

  • Diabetes & Glandular Disease Clinic, P.A.

    San Antonio, Texas, 78229, United States

  • Dr. T.G Elliott Inc. dba BC Diabetes

    Vancouver, British Columbia, Canada

  • Lucas Research, Inc.

    Morehead City, North Carolina, 28577, United States

  • Manassas Clinical Research Center

    Manassas, Virginia, 20110, United States

  • Oceanic Research Group

    North Miami Beach, Florida, 33169, United States

  • Texas Diabetes & Endocrinology

    Round Rock, Texas, 78681, United States

  • University Diabetes & Endocrine Consultants

    Chattanooga, Tennessee, 37411, United States

  • Velocity Clinical Research

    Dallas, Texas, 75230, United States

Conditions

Explore the condition pages connected to this study.